Lobbying Information
Subject Matters
- Aboriginal Affairs
- Budget
- Economic Development
- Health
- Industry
- International Trade
- Labour
- Research and Development
- Science and Technology
Subject Matter Details
Grant, Contribution or Other Financial Benefit, Policies or Program
- Strategic Innovation Fund (SIF), with regards to medical technology.
Legislative Proposal, Bill or Resolution
- Federal Budget & Budget Measures Act with respect to health care funding and focus on science, technology & innovation
- Regulatory Cooperation Council (RCC) work and focus on medical devices regulations
Policies or Program
- Federal Chemicals Management Plan, with respect to specific batch chemical reviews that may include a chemical used in our manufacturing operations in Canada
- Federal Innovation Panel (lead by Health Canada), focused on medical technologies commercialization and adoption in Canada
- Indigenous policies concerning health
- Science & Technology strategy with respect to the impact on commercialization and/or procurement of medical technology in Canada
Policies or Program, Regulation
- Comprehensive Economic and Trade Agreement (CETA), North American Free Trade Agreement (NAFTA) and Trans Pacific Partnership (TPP) trade discussions with a focus on medical devices regulations
Regulation
- Regulations to Amend the Food and Drugs Act - with respect to provisions that would impact approvals and product life-cycle management for medical devices and biopharmaceuticals, subsequent entry biologics regulations, orphan/rare disease direction and the disclosure of confidential business information
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous and Northern Affairs Canada
-
Innovation, Science and Economic Development Canada (ISED)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
7125 Mississauga Rd.
Mississauga, ON L5N 0C2
Canada
Telephone number:
905-369-6576
Web address:
http://www.baxter.ca/en
Client representative
Sebastien Beauchamp, Vice President, Government Affairs, Public Policy & Market Access
Parent Company Information
- Baxter International
-
One Baxter Parkway
Deerfield, IL 60015
United States of America
Coalition Members Information
Baxter Corporation is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Baxter Corporation are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Baxter Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Paul Moen
|
Public offices held
Business address:
46 Elgin Street, Suite 200
Ottawa, ON K1P 5K6
Canada
Telephone number:
613-853-5553
Consultant Firm and Address
Firm:
Earnscliffe Strategy Group Inc.
Address:
46 Elgin Street, Suite 200
Ottawa, ON K1P 5K6
Canada
Telephone number:
613-853-5553
